Isthmus Partners’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-22,018
Closed -$342K 269
2018
Q1
$342K Buy
22,018
+3,141
+17% +$56K 0.09% 116
2017
Q4
$356K Buy
18,877
+816
+5% +$18.1K 0.1% 115
2017
Q3
$527K Buy
18,061
+636
+4% +$18.8K 0.15% 103
2017
Q2
$561K Buy
17,425
+74
+0.4% +$2.43K 0.16% 101
2017
Q1
$600K Buy
17,351
+556
+3% +$19.9K 0.18% 98
2016
Q4
$593K Buy
16,795
+246
+1% +$8.31K 0.18% 102
2016
Q3
$554K Buy
16,549
+514
+3% +$18K 0.18% 99
2016
Q2
$599K Sell
16,035
-83
-0.5% -$3.12K 0.2% 88
2016
Q1
$651K Buy
16,118
+63
+0.4% +$2.35K 0.22% 78
2015
Q4
$578K Buy
16,055
+828
+5% +$30K 0.2% 88
2015
Q3
$486K Buy
15,227
+272
+2% +$9.26K 0.18% 89
2015
Q2
$508K Buy
14,955
+827
+6% +$27.9K 0.17% 98
2015
Q1
$478K Buy
14,128
+554
+4% +$19.3K 0.16% 95
2014
Q4
$477K Buy
+13,574
New +$457K 0.16% 97

Other funds holding ACH

Isthmus Partners's ACH Position: Q2 2018 in Review

Isthmus Partners sold out of Accendra Health (ACH) in Q2 2018, closing a stake of 22,018 shares — an estimated $342K sold.

Isthmus Partners first reported a position in ACH in Q4 2014 and held it in 14 quarters. The position peaked at $651K in Q1 2016. 229 funds tracked by Wall St. Rank hold ACH as of Q2 2018.

  • Isthmus Partners reported no remaining Accendra Health position as of Q2 2018 after selling out during the quarter.
  • Isthmus Partners sold 22,018 Accendra Health shares in Q2 2018, an estimated $342K.
  • Isthmus Partners first reported a position in Accendra Health in Q4 2014 and held it in 14 quarters.
  • Isthmus Partners's Accendra Health position peaked at $651K in Q1 2016.
  • 229 funds tracked by Wall St. Rank held Accendra Health as of Q2 2018.

Based on Isthmus Partners's 13F filing for Q2 2018, filed 2 Aug 2018.